Orchestra BioMed Holdings, Inc.OBIONASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower.
Left:
||||
Year-over-year research & development expense growth
Latest
26.56%
Near historical average
Average (4y)
29.31%
Historical baseline
Range
High:70.25%
Low:-4.36%
Volatility
254.5%
High variability
| Period | Value |
|---|---|
| 2024 | 26.56% |
| 2023 | 54.12% |
| 2022 | 70.25% |
| 2021 | -4.36% |
| 2020 | 0.00% |